Type 1 diabetes

Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes

Diabetes CarePublished Cross-sectional study

Authors' conclusion

Technology use was associated with lower HbA1c across all socioeconomic backgrounds. Socioeconomic disadvantage does not preclude glycemic benefits of diabetes technologies, highlighting the need to remove barriers to technology access.

Study context

Population
Australian youth with T1D; Socioeconomic status (SES) assigned from residential postcode by Index of Relative Socio-Economic Disadvantage (IRSD) quintile
Participants
2,822 participants
Exposure
Diabetes technology use vs none, across IRSD quintiles
Outcome
HbA1c by IRSD quintile and management regimen

Main finding

As reported in the abstract

Mean HbA1c
Insulin pump therapy, CGM and their concurrent use associated with lower mean HbA1c across all IRSD quintiles
P < 0.001
No interaction between technology use and IRSD quintile on HbA1c
P = 0.624

Observational data: associations, not effects.

Original publication

Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes. Diabetes Care. Published 7 February 2024. doi:10.2337/dc23-2033

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.